Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease

被引：136

作者：

Villemagne, Victor L. ^{[2
,3
]}

Klunk, William E. ^{[4
]}

Mathis, Chester A. ^{[5
]}

Rowe, Christopher C. ^{[2
,3
]}

Brooks, David J. ^{[6
,7
]}

Hyman, Bradley T.

Ikonomovic, Milos D. ^{[9
]}

Ishii, Kenji ^{[10
]}

Jack, Clifford R. ^{[11
]}

Jagust, William J. ^{[12
]}

Johnson, Keith A. ^{[8
,13
]}

Koeppe, Robert A. ^{[14
]}

Lowe, Val J. ^{[11
]}

Masters, Colin L. ^{[15
]}

Montine, Thomas J. ^{[16
]}

Morris, John C. ^{[17
]}

Nordberg, Agneta ^{[18
]}

Petersen, Ronald C. ^{[19
]}

Reiman, Eric M. ^{[20
]}

Selkoe, Dennis J. ^{[8
]}

Sperling, Reisa A. ^{[8
]}

Van Laere, Koen ^{[21
]}

Weiner, Michael W. ^{[22
]}

Drzezga, Alexander ^{[1
]}

机构：

[1] Tech Univ Munich, Dept Nucl Med, Munich, Germany

[2] Austin Hlth, Dept Nucl Med, Heidelberg, Vic, Australia

[3] Austin Hlth, Ctr PET, Heidelberg, Vic, Australia

[4] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA

[5] Univ Pittsburgh, Sch Med, Dept Radiol, Pittsburgh, PA USA

[6] Univ London Imperial Coll Sci Technol & Med, Dept Med, London SW7 2AZ, England

[7] GE Healthcare, Med Diagnost, Amersham, Bucks, England

[8] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA

[9] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA

[10] Tokyo Metropolitan Inst Gerontol, Positron Med Ctr Clin, Itabashi Ku, Tokyo, Japan

[11] Mayo Clin, Dept Radiol, Rochester, MN USA

[12] Univ Calif Berkeley, Berkeley, CA 94720 USA

[13] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA

[14] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA

[15] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3052, Australia

[16] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA

[17] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA

[18] Karolinska Univ Hosp, Dept Neurobiol Care Sci & Soc, Karolinska Inst, Stockholm, Sweden

[19] Mayo Clin, Dept Neurol, Coll Med, Rochester, MN USA

[20] Univ Arizona, Banner Alzheimers Inst, Phoenix, AZ USA

[21] Katholieke Univ Leuven Hosp, Div Nucl Med, Louvain, Belgium

[22] Univ Calif San Francisco, Ctr Imaging Neurodegenerat Dis, San Francisco Vet Affairs Med Ctr, San Francisco, CA 94143 USA

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷 / 02期

基金：

英国医学研究理事会;

关键词：

PITTSBURGH COMPOUND-B; POSITRON-EMISSION-TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; CEREBRAL AMYLOID ANGIOPATHY; C-11-PIB PET; NEUROPATHOLOGIC ASSESSMENT; LEWY BODIES; MOUSE MODEL; HUMAN BRAIN; PIB-PET;

D O I：

10.1007/s00259-011-2045-0

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：209 / 219

页数：11

共 90 条

[51] Comparison of relative cerebral blood flow maps using pseudo-continuous arterial spin labeling and single photon emission computed tomography
Liu, Peiying
Uh, Jinsoo
Devous, Michael D.
Adinoff, Bryon
Lu, Hanzhang
[J]. NMR IN BIOMEDICINE, 2012, 25 (05) : 779 - 786
[52] PIB is a non-specific imaging marker of amyloid-beta (Aβ) peptide-related cerebral amyloidosis
Lockhart, A.
Lamb, J. R.
Osredkar, T.
Sue, L. I.
Joyce, J. N.
Ye, L.
Libri, V.
Leppert, D.
Beach, T. G.
[J]. BRAIN, 2007, 130 : 2607 - 2615
[53] Comparison of 18F-FDG and PiB PET in Cognitive Impairment
Lowe, Val J.
Kemp, Bradley J.
Jack, Clifford R., Jr.
Senjem, Matthew
Weigand, Stephen
Shiung, Maria
Smith, Glenn
Knopman, David
Boeve, Bradley
Mullan, Brian
Petersen, Ronald C.
[J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (06) : 878 - 886
[54] Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography
Maeda, Jun
Ji, Bin
Irie, Toshiaki
Tomiyama, Takami
Maruyama, Masahiro
Okauchi, Takashi
Staufenbiel, Matthias
Iwata, Nobuhisa
Ono, Maiko
Saido, Takaomi C.
Suzuki, Kazutoshi
Mori, Hiroshi
Higuchi, Makoto
Suhara, Tetsuya
[J]. JOURNAL OF NEUROSCIENCE, 2007, 27 (41) : 10957 - 10968
[55] Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents
Mathis, CA
Wang, YM
Holt, DP
Huang, GF
Debnath, ML
Klunk, WE
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (13) : 2740 - 2754
[56] THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD) .2. STANDARDIZATION OF THE NEUROPATHOLOGIC ASSESSMENT OF ALZHEIMERS-DISEASE
MIRRA, SS
HEYMAN, A
MCKEEL, D
SUMI, SM
CRAIN, BJ
BROWNLEE, LM
VOGEL, FS
HUGHES, JP
VANBELLE, G
BERG, L
[J]. NEUROLOGY, 1991, 41 (04) : 479 - 486
[57] Amyloid-β imaging with PET in Alzheimer's disease: is it feasible with current radiotracers and technologies?
Moghbel, Mateen C.
Saboury, Babak
Basu, Sandip
Metzler, Scott D.
Torigian, Drew A.
Langstrom, Bengt
Alavi, Abass
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (02) : 202 - 208
[58] APOE Predicts Amyloid-Beta but Not Tau Alzheimer Pathology in Cognitively Normal Aging
Morris, John C.
Roe, Catherine M.
Xiong, Chengjie
Fagan, Anne M.
Goate, Alison M.
Holtzman, David M.
Mintun, Mark A.
[J]. ANNALS OF NEUROLOGY, 2010, 67 (01) : 122 - 131
[59] Mufson EJ., 2011, Acta Neuropathol
[60] Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline
Näslund, J
Haroutunian, V
Mohs, R
Davis, KL
Davies, P
Greengard, P
Buxbaum, JD
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (12): : 1571 - 1577

← 1 2 3 4 5 6 7 8 9 →